Bos O J, Fischer M J, Wilting J, Janssen L H
Department of Pharmaceutical Chemistry, Faculty of Pharmacy, State University of Utrecht, The Netherlands.
Biochim Biophys Acta. 1988 Mar 2;953(1):37-47. doi: 10.1016/0167-4838(88)90007-6.
The diazepam-binding behaviour of a large tryptic and a large peptic fragment of human serum albumin has been studied by circular dichroism and equilibrium dialysis in order to locate the primary diazepam-binding site on the albumin molecule. The analytical set-up of the FPLC was used to find the optimum experimental conditions for isolating the fragments. Conventional columns with a 100-fold higher loading capacity than the analytical FPLC columns were used to isolate large amounts of the fragments. The isolation procedure for the tryptic fragment (45 kDa, domains two and three of the albumin structure) is described in this paper. The description of the isolation procedure for the peptic fragment (46 kDa, domains one and two of the albumin structure) is published elsewhere (Bos, O.J.M., Fischer, M.J.E., Wilting, J. and Janssen, L.H.M. (1988) J. Chromatogr. 424, 13-21). The induced ellipticity of the diazepam-fragment complexes as well as the affinity of diazepam to the fragments turned out to be pH dependent. This pH dependence occurs in the region of the neutral to base transition of the albumin molecule. Difference CD-spectra of the proteins showed that the tryptic fragment and albumin have similar diazepam-binding properties, whereas the peptic fragment has different diazepam-binding properties. This result is in line with our equilibrium dialysis experiments which showed that the affinity of diazepam to the tryptic fragment and to albumin is of the same order of magnitude, whereas the affinity of diazepam to the peptic fragment is several orders of magnitude lower. On the basis of these results, it can be concluded that the tryptic fragment contains the primary diazepam-binding site and the peptic fragment one or more secondary diazepam-binding sites. This means that at least the main part of the primary diazepam-binding site is located in domain three of the albumin structure.
为了确定人血清白蛋白分子上主要的地西泮结合位点,通过圆二色性和平衡透析研究了人血清白蛋白的一个大的胰蛋白酶片段和一个大的胃蛋白酶片段的地西泮结合行为。使用FPLC的分析装置来寻找分离片段的最佳实验条件。使用比分析型FPLC柱负载能力高100倍的常规柱来分离大量片段。本文描述了胰蛋白酶片段(45 kDa,白蛋白结构的结构域二和三)的分离过程。胃蛋白酶片段(46 kDa,白蛋白结构的结构域一和二)的分离过程描述见其他文献(Bos, O.J.M., Fischer, M.J.E., Wilting, J. and Janssen, L.H.M. (1988) J. Chromatogr. 424, 13 - 21)。地西泮 - 片段复合物的诱导椭圆率以及地西泮与片段的亲和力结果表明其依赖于pH值。这种pH依赖性发生在白蛋白分子从中性到碱性转变的区域。蛋白质的差示圆二色光谱表明,胰蛋白酶片段和白蛋白具有相似的地西泮结合特性,而胃蛋白酶片段具有不同的地西泮结合特性。这一结果与我们的平衡透析实验一致,该实验表明地西泮与胰蛋白酶片段和白蛋白的亲和力处于同一数量级,而地西泮与胃蛋白酶片段的亲和力则低几个数量级。基于这些结果,可以得出结论,胰蛋白酶片段包含主要的地西泮结合位点,而胃蛋白酶片段包含一个或多个次要的地西泮结合位点。这意味着至少主要的地西泮结合位点的主要部分位于白蛋白结构的结构域三中。